Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Haese

Showing results (91-100 of 214) with videos related to

Pageof 22
Sort By:
Urologic Oncology|February 6, 2017
Radical prostatectomy neutralizes obesity-driven risk of prostate cancer progressionJonas Schiffmann, Georg Salomon, Derya Tilki, et al.
BJU International|September 30, 2010
Prediction of patient-specific risk and percentile cohort risk of pathological stage outcome using continuous prostate-specific antigen measurement, clinical stage and biopsy Gleason scoreYing Huang, Sumit Isharwal, Alexander Haese, et al.
International Journal of Cancer|September 10, 2005
Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serumThomas Steuber, Andrew J Vickers, Alexander Haese, et al.
Urologia Internationalis|January 19, 2016
Differences in Patient Characteristics Among Men Choosing Open or Robot-Assisted Radical Prostatectomy in Contemporary Practice at a European High-Volume CenterJonas Schiffmann, Alexander Haese, Jochen Lenz, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|August 12, 2009
TMPRSS2:ERG fusion transcripts in urine from prostate cancer patients correlate with a less favorable prognosisKari Rostad, Olaf J C Hellwinkel, Svein A Haukaas, et al.
World Journal of Urology|January 19, 2023
Histopathological results of radical prostatectomy specimen of men younger than 50 years of age at the time of surgery: possible implications for prostate cancer screening programs?Gisa Mehring, Derya Tilki, Hans Heinzer, et al.
European Urology|July 13, 2010
External validation of urinary PCA3-based nomograms to individually predict prostate biopsy outcomeMarco Auprich, Alexander Haese, Jochen Walz, et al.
European Urology|October 29, 2010
Critical assessment of preoperative urinary prostate cancer antigen 3 on the accuracy of prostate cancer stagingMarco Auprich, Felix K-H Chun, John F Ward, et al.
World Journal of Urology|March 13, 2024
Robot-assisted vs open retropubic radical prostatectomy: a propensity score-matched comparative analysis based on 15 years and 18,805 patientsFrancesca Ambrosini, Sophie Knipper, Derya Tilki, et al.
BJU International|January 23, 2026
Diagnostic accuracy and outcomes of lymph node staging in intermediate-risk prostate cancerChristopher Kniep, Tobias Maurer, Ben Frederik Hartwieg, et al.
Pageof 22

Showing results (91-100 of 214) with videos related to

Sort By:
Pageof 22
Urologic Oncology|February 6, 2017
Radical prostatectomy neutralizes obesity-driven risk of prostate cancer progressionJonas Schiffmann, Georg Salomon, Derya Tilki, et al.
BJU International|September 30, 2010
Prediction of patient-specific risk and percentile cohort risk of pathological stage outcome using continuous prostate-specific antigen measurement, clinical stage and biopsy Gleason scoreYing Huang, Sumit Isharwal, Alexander Haese, et al.
International Journal of Cancer|September 10, 2005
Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serumThomas Steuber, Andrew J Vickers, Alexander Haese, et al.
Urologia Internationalis|January 19, 2016
Differences in Patient Characteristics Among Men Choosing Open or Robot-Assisted Radical Prostatectomy in Contemporary Practice at a European High-Volume CenterJonas Schiffmann, Alexander Haese, Jochen Lenz, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|August 12, 2009
TMPRSS2:ERG fusion transcripts in urine from prostate cancer patients correlate with a less favorable prognosisKari Rostad, Olaf J C Hellwinkel, Svein A Haukaas, et al.
World Journal of Urology|January 19, 2023
Histopathological results of radical prostatectomy specimen of men younger than 50 years of age at the time of surgery: possible implications for prostate cancer screening programs?Gisa Mehring, Derya Tilki, Hans Heinzer, et al.
European Urology|July 13, 2010
External validation of urinary PCA3-based nomograms to individually predict prostate biopsy outcomeMarco Auprich, Alexander Haese, Jochen Walz, et al.
European Urology|October 29, 2010
Critical assessment of preoperative urinary prostate cancer antigen 3 on the accuracy of prostate cancer stagingMarco Auprich, Felix K-H Chun, John F Ward, et al.
World Journal of Urology|March 13, 2024
Robot-assisted vs open retropubic radical prostatectomy: a propensity score-matched comparative analysis based on 15 years and 18,805 patientsFrancesca Ambrosini, Sophie Knipper, Derya Tilki, et al.
BJU International|January 23, 2026
Diagnostic accuracy and outcomes of lymph node staging in intermediate-risk prostate cancerChristopher Kniep, Tobias Maurer, Ben Frederik Hartwieg, et al.
Pageof 22